Cure My Disease

Don't miss your cure!

Log in / Sign up

← Back to home

Kodiak Sciences Inc

Clinical trials sponsored by Kodiak Sciences Inc, explained in plain language.

Kodiak Sciences KOD NASDAQ

Ophthalmology biotech focused on retinal disease treatments.

Trade on eToro (ad)

Not investment advice. Company information is shown for context only. Clinical trials frequently fail.

Trials to join now! 2 Not yet recruiting 1 Not yet finished but already full! 1 Completed 1

Can a new eye injection beat the current standard for diabetic vision loss?

Disease control Not yet recruiting

This phase 3 trial compares an experimental drug, tabirafusp tedromer, against the standard treatment aflibercept for people with diabetic macular edema (DME), a leading cause of vision loss in diabetes. About 910 adults with DME will receive injections into the eye and be follow…

Phase: PHASE3 • Sponsor: Kodiak Sciences Inc • Aim: Disease control

Last updated Jul 31, 2026 00:00 UTC